Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Sep-Oct;8(5):204-209.
doi: 10.1016/j.aace.2022.06.001. Epub 2022 Jun 15.

A Case of Hypophysitis Associated With SARS-CoV-2 Vaccination

Affiliations
Case Reports

A Case of Hypophysitis Associated With SARS-CoV-2 Vaccination

Anvitha R Ankireddypalli et al. AACE Clin Case Rep. 2022 Sep-Oct.

Abstract

Background/objective: Although SARS-CoV-2 vaccines have been developed with multiple novel technologies and rapidly disseminated worldwide, the full profile of adverse effects has not been known. Recently, there are sporadic but increasing reports of endocrinopathy in relation to SARS-CoV-2 vaccination. Here we report a rare case of hypophysitis with acute onset of diabetes insipidus, immediately after SARS-CoV-2 vaccination.

Case report: A 48-year-old female patient had been in her usual state of health until she received the first SARS-CoV-2 vaccine. Two days after vaccination, she started to have flu-like symptoms, including severe headache and myalgia as well as persistent headache, polydipsia, and polyuria. She was diagnosed with diabetes insipidus, and magnetic resonance imaging revealed thickening of the pituitary stalk. Three months after vaccination, her symptoms had somewhat improved, but she still had pituitary stalk thickening on magnetic resonance imaging.

Discussion: Given the timing of the occurrence of diabetes insipidus, we believe that the patient's hypophysitis may be associated with SARS-CoV-2 vaccination. We also found 19 cases of endocrinopathy after SARS-CoV-2 vaccination by literature search. The reported endocrine organs were the thyroid, pituitary, and adrenals. Twelve cases of diabetes were also reported. Among 3 pituitary cases, diabetes insipidus was reported only in our case.

Conclusion: We report a rare case of SARS-CoV-2 vaccine-triggered hypophysitis, which led to diabetes insipidus. SARS-CoV-2 vaccine-related endocrinopathy seems, indeed, possible. Endocrinopathy is associated with infrequent complications; however, it may be underestimated in the post-SARS-CoV-2-vaccinated population. Further studies are warranted to better understand SARS-CoV-2 vaccine-related endocrinopathy.

Keywords: IGF1, insulin-like growth factor 1; IgG, immunoglobulin G; MRI, magnetic resonance imaging; SARS-CoV-2 vaccination; diabetes insipidus; endocrinopathy; hypophysitis.

PubMed Disclaimer

Figures

Fig
Fig
Brain magnetic resonance imaging. Brain sagittal (left) and coronal (right) T1-weighted MR images with gadolinium contrast. A, The MR images after the second vaccine show pituitary stalk thickening (yellow arrow) and a partially empty sella (red arrow). B, The MR images 3 months after hospitalization show unchanged pituitary stalk thickening (yellow arrow) and a partially empty sella (red arrow). C, Hourly urine output during the water deprivation test. The x-axis shows the time after hospitalization. Each bar represents urine output in each hour. The red arrow indicates the timing of DDAVP administration.

References

    1. Creech C.B., Walker S.C., Samuels R.J. SARS-CoV-2 vaccines. JAMA. 2021;325(13):1318–1320. - PubMed
    1. Kyriakidis N.C., López-Cortés A., González E.V., Grimaldos A.B., Prado E.O. SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates. NPJ Vaccines. 2021;6(1):28. - PMC - PubMed
    1. Arzt E., Pereda M.P., Castro C.P., Pagotto U., Renner U., Stalla G.K. Pathophysiological role of the cytokine network in the anterior pituitary gland. Front Neuroendocrinol. 1999;20(1):71–95. - PubMed
    1. Leal A.M., Magalhães P.K., Souza C.S., Foss N.T. Pituitary-gonadal hormones and interleukin patterns in leprosy. Trop Med Int Health. 2006;11(9):1416–1421. - PubMed
    1. Postow M.A., Sidlow R., Hellmann M.D. Immune-related adverse events associated with immune checkpoint blockade. N Engl J Med. 2018;378(2):158–168. - PubMed

Publication types